[Profile of patients with diabetes type 1: insulinotherapy and self-monitoring].
OBJECTIVE
A study carried out in Londrina - PR, with the cohort of local patients from Brazilian Study on the incidence of Diabetes Mellitus Type 1 (EDID). To know the insulin treatment and the plan for glycemic self-monitoring used by these patients; to verify their knowledge as for what they consider the optimization of these parameters and limitations of use.


METHODS
A survey was conducted with objective questions to 63 patients of the cohort.


RESULTS
The average age was 13 years, without gender predominance. It was verified that most of the patients, 79.36%, (n=50) took at least 2 daily applications of insulin. All of them used insulin NPH in one (n=13) or two (n=50) doses. The use of regular insulin, in variable programs, was associated to the NPH in 41.27% (n=26) of the patients (The most frequent insulin type used was human 53.97% (n=34). Of the patients not making use of human insulin, 44.83% (n=13) considered it of high cost and 95.24% (n=60) would make use of it if it was distributed by the Government Unified Health System. As for the monitoring, 63.40% (n=40) took the tests up to 7 times a week, 20.63% (n=13) from 15 to 21 and only 1 patient from 29 to 35 tests. The high cost was the reason for 48.21% (n=27) not to take the tests; 58.73% (n=37) would take the test in the blood and 33.33% (n=21) either in the blood or in the urine if they were given the reactive ribbons.


CONCLUSIONS
In this cohort of patients, although the human insulin is already adopted as the use of choice, the outline insulin treatment plan is still traditional and the monitoring is far behind the ideal.
Almeida
Henriqueta Galvanin Guidio de
HG
Centro de Ciências da Saúde, Universidade Estadual de Londrina, PR.
Campos
Joao Jose Batista
JJ
Kfouri
Christiane
C
Tanita
Marcos Toshiyuki
MT
Dias
Adriana Espinosa
AE
Souza
Marizia Marcos de
MM
D000293:Adolescent; D000328:Adult; D015190:Blood Glucose Self-Monitoring; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007336:Insulin, Isophane / Q000008:administration & dosage / Q000627:therapeutic use*; D007407:Interviews as Topic; D008297:Male
D007004:Hypoglycemic Agents; D007336:Insulin, Isophane